Lam Research Corporation $LRCX Stock Position Lowered by Migdal Insurance & Financial Holdings Ltd.

Migdal Insurance & Financial Holdings Ltd. decreased its position in Lam Research Corporation (NASDAQ:LRCX) by 68.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,958 shares of the semiconductor company’s stock after selling 6,409 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in Lam Research were worth $288,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Bahl & Gaynor Inc. lifted its holdings in Lam Research by 1.9% in the 2nd quarter. Bahl & Gaynor Inc. now owns 5,602 shares of the semiconductor company’s stock valued at $545,000 after acquiring an additional 102 shares during the last quarter. BankPlus Wealth Management LLC lifted its stake in Lam Research by 2.0% during the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after purchasing an additional 105 shares during the last quarter. ORG Partners LLC boosted its holdings in Lam Research by 7.3% during the second quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock worth $162,000 after buying an additional 114 shares in the last quarter. Quotient Wealth Partners LLC grew its position in Lam Research by 2.1% in the second quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock worth $529,000 after buying an additional 114 shares during the last quarter. Finally, Fairvoy Private Wealth LLC grew its position in Lam Research by 3.0% in the second quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock worth $407,000 after buying an additional 120 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 102,608 shares of company stock worth $14,916,496 in the last 90 days. 0.31% of the stock is currently owned by company insiders.

Lam Research Stock Down 4.9%

LRCX opened at $160.52 on Monday. The company has a market capitalization of $201.62 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $169.69. The business has a 50-day moving average of $152.53 and a 200-day moving average of $120.50.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Analysts Set New Price Targets

Several research firms have recently weighed in on LRCX. BNP Paribas Exane raised their price objective on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. The Goldman Sachs Group upped their target price on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. Susquehanna lifted their price objective on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research report on Thursday, October 23rd. Hsbc Global Res raised Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Finally, Wells Fargo & Company upped their price target on Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $152.87.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.